Curious minds select the most fascinating podcasts from around the world. Discover hand-piqd audio recommendations on your favorite topics.
piqer for: Health and Sanity Boom and bust Climate and Environment
Melissa Hutsell is an award-winning freelance journalist with a deep rooted passion for both community and international journalism. She was born and raised in Northern California, and has lived, studied, worked, and traveled in more 20 different countries. Melissa holds a Master's degree in Global Journalism from City University London, as well as degrees in Journalism and Globalization from Humboldt State University. Though she covers various topics as both a writer and editor, she specializes in business and cannabis journalism.
Countries such as the Netherlands have created a catalyst for the legal international cannabis market. That market is growing, thanks to countries such as Canada, the US, Israel and Germany (among others) who’ve passed policy allowing the medicinal or recreational use of cannabis.
Growing markets are fueling business. Exports, such as extracts for medicinal products, are developing a demand across borders. More and more countries, from Australia to Brazil, and Finland to Italy, are opening trade to this heavily regulated and now legal market.
While the industry grows, so does cannabis use across the globe. In 2014 alone, the UN estimated that nearly 185 million used the plant at least once per year, especially in the EU and North America.
Despite varying legal frameworks, the need for medical cannabis products may hold the most potential for businesses who seek global markets. This is due to the nature of medicine; it’s controlled. “The [Single Convention on Narcotic Drugs …] categorizes cannabis as a Schedule IV drug, which under the treaty’s terms is the highest level of control alongside synthetic opioids,” stated the article. “The treaty recognizes and encourages scientific and medical use of controlled substances, but not recreational uses.”